Use OF 5% Traneximic acid procedural mouthrinse in reducing Bleeding On Probing during clinical examination of gum diseass

Efficacy of five percentage traneximic acid preprocedural mouth rinse in reducing bleeding on probing BOP during clinical examination in biofilm induced gingival disease in comparision to placebo. A randomised clinical trial. - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/102965

Enrollment

Registered

2026-02-04

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K051- Chronic gingivitis

Interventions

Intervention1: 5 percentage traneximic acid mouth rinsing: 5 percentage traneximic acid mouth rinsing prepared from 500mg traneximic acid tablet half an hour before clinical probing Control Interventi

Eligibility

Inclusion criteria

Inclusion criteria: Biofilm induced gingival disease with gingival index score of greater than or equal to two

Exclusion criteria

Exclusion criteria: patients with systemic disease like diabetes or bleeding clotting disorders or using medications that affect bleeding and clotting mechanisms or smokers or patients allergic to traneximic acid or any components of the mouthwash will be excluded from the study

Design outcomes

Primary

Measure	Time frame
Bleeding on probing following clinical examination with periodontal probeTimepoint: Baseline, thirty minutes	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr S Janitha

Government dental college and research Institute, Bangalore

janitha.s@rediffmail.com9901119025

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026